Innovation

Remotely Triggered Liposomal Drug Release

University of California System: University of California, Santa Barbara
posted on 07/23/2009

 A method to create the rapid release of a therapeutic agent from liposomes to the targeted area.

Suggested Uses

  • Drug Delivery
  • Chemotherapy (Breast cancer, prostate cancer)
  • Kidney stone treatments
  • DNA/RNA delivery

 

The technology is available for licensing. Patent pending.


Advantages

  • Rapid release of therapeutic at target site
  • Elimination of need for large scale heating or irradiation
  • No toxic reagents required
  • Simpler fabrication than gold/silica core nanoparticles
  • Optimizes existing liposome fabrication and delivery methods

Innovation Details
 

Detailed Description

Researchers at the University of California, Santa Barbara, have developed a method of using hollow gold nanospheres (HGN) located within or tethered to liposomes, together with pulsed near infrared (NIR) laser irradiation, to create the rapid release of a therapeutic agent from liposomes to the targeted area. In situ tests have demonstrated that this method ruptures over 90% of the liposomes in approximately 10 seconds, without use of toxic reagents or the need to heat large scale areas.

File Number: 19354 

Other Information:

Background
For many years, researchers have been seeking commercially viable methods to initiate a rapid release of encapsulated drugs at the site of disease through an external triggering mechanism. Liposomes have been intensively investigated for this application. Large scale hypothermia, ultrasound or visible light have been used to rupture liposomes to accomplish targeted delivery. Unfortunately, these methods are limited to easily accessible areas, such as the eyes and skin. Gold nanoshells grown around silica cores have also been used to selectively heat and kill tumor cells, but the maximum temperature reached by continuous heating is limited to 10-20 C above background and the entire region to be heated must be saturated with nanoshells, which is difficult to accomplish. Gold/silica core nanoparticles are also difficult to manufacture. Hollow gold nanoshells have also been explored, but current methods require the use of toxic reagents or high temperatures.


IP Protection

Copyright: ©2009-2010, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact Franco Caporale at University of California System: University of California, Santa Barbara for more information.

Request more info via email request more info
People

Case Manager:

Franco Caporale Franco Caporale

Innovations (75)

Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

4,588 members 13,287 innovations 113 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...